NCD Policy Lab

NCD Policy Lab The NCD Policy Lab seeks to move the access to medicines and technologies agenda forward.

À Djibouti, Santé Diabète et l’Université de Genève, avec le soutien du Ministère de la Santé, ont conduit une évaluatio...
13/07/2026

À Djibouti, Santé Diabète et l’Université de Genève, avec le soutien du Ministère de la Santé, ont conduit une évaluation de l’accès à l’insuline, en utilisant ce médicament essentiel comme traceur de la prise en charge du diabète.

Cette analyse a permis d’examiner l’ensemble de la chaîne de soins : approvisionnement, organisation du système de santé, disponibilité des traitements, accès aux soins et accessibilité financière.

Des visites de terrain ont été réalisées à tous les niveaux de la pyramide sanitaire, à Djibouti-Ville comme dans les régions, avant une restitution des résultats au Secrétaire Général du Ministère de la Santé.

Université de Genève, ONG Santé Diabète

For people living with  , ensuring access to insulin and essential supplies is the first priority. But what should come ...
06/07/2026

For people living with , ensuring access to insulin and essential supplies is the first priority. But what should come next to improve care?

Published in the Lancet Diabetes & Endocrinology, this study, led by Sanjay Basu, Jessica Zafra-Tanaka and David Beran as part of the work of the , set out to answer this question.

By combining a systematic review, an international process involving experts and people with lived experience, and a WHO-CHOICE micro-simulation, the study identified interventions, grouped them into clusters, and estimated their cost-effectiveness in resource-limited settings.

What did the study find? Clusters of interventions may generate greater health gains than individual interventions. However, they also require greater investment.
This suggests that a step-by-step approach may be the most appropriate when resources are limited. The study provides evidence on where to start, while recognizing that the best decisions should always be guided by local needs, available resources, and implementation capacity.

Why does this study matter?
Previous research has mainly focused on individual interventions in high-income countries. This study goes one step further by:
☑️ Evaluating clusters of interventions validated by an international panel, including people with lived experience;
☑️ Estimating cost-effectiveness using GDP-standardized metrics, making the findings comparable across different economic settings and supporting priority-setting globally.

Read the paper:

💬 In your context, what are the greatest unmet needs in type 1 diabetes care? According to the resources and implementation capacities in your setting, which interventions should be prioritized?

**
This work was supported by Breakthrough T1D as part of The Lancet Diabetes & Endocrinology Commission on Type 1 Diabetes ( ), with additional support from the World Diabetes Foundation and the Swiss Development & Cooperation

Temperatures were high in Geneva this week, but so was the level of discussion for the NCD Policy Lab   2026!Over the pa...
25/06/2026

Temperatures were high in Geneva this week, but so was the level of discussion for the NCD Policy Lab 2026!

Over the past two days in Geneva, partners from the NCD Policy Lab ecosystem, CRONICAS - Centro de Excelencia en Enfermedades Crónicas, HPAC, Université de Genève and ONG Santé Diabète, came together for a coordination meeting to review progress, reflect on lessons learned, and shape the next phase of collaboration.

The conversations were not only about what had been achieved, but also about what had been learned. What worked well? What proved more difficult than expected? What lessons emerged, and how should they inform future activities?
Through presentations, discussions, and collaborative brainstorming sessions, partners exchanged experiences, identified challenges, and explored opportunities to strengthen the collective impact of the NCD Policy Lab .

Looking ahead, discussions focused on priorities for the next years and ways to enhance collaboration and synergies across countries and institutions.
One theme consistently emerged: meaningful progress depends not only on generating evidence, but also on creating opportunities to learn from one another.

The insights shared during these days will help guide the next chapter of the NCD Policy Lab's work to advance access to NCD care, medicines, and technologies through the adoption of evidence-informed policies.

A sincere thank you to our partners for their engagement, insights, and continued partnership. Looking forward to translating these discussions into action! 🚀

"The private sector often imposes its rules, to the detriment of the public interest. In response to this, governments m...
23/06/2026

"The private sector often imposes its rules, to the detriment of the public interest. In response to this, governments must fully assume their role as countervailing powers. They have the levers in their hands to change the situation.
They must invest in research and innovation, regulate an overly concentrated market, fund strong health systems and protect their population from predatory pricing." - Prof. David Beran & Besancon Stéphane

In this article published in The Conversation and available in both and , Prof. David Beran and Stéphane Besançon highlight why access to insulin, a life-saving treatment, remains unequal worldwide. Market concentration, high prices, and fragile health systems continue to limit access.

Ensuring insulin for all is not only a public health priority, it is a matter of .

📖 Read the article: https://theconversation.com/why-insulin-the-core-element-of-diabetes-treatment-remains-inaccessible-for-millions-of-people-284194

ONG Santé Diabète

22/06/2026

💉 Insulin was discovered more than a century ago. Yet for many people living with around the world, access to this life-saving medicine remains far from guaranteed.

In the latest newsletter of the Fondation pour la Recherche sur le Diabète, Prof. David Beran explores the realities of type 1 diabetes in low- and middle-income countries ( ).

The article highlights how barriers to insulin, diagnostics, diabetes education, and specialist care continue to shape health outcomes and why addressing these challenges remains a critical global health priority.

📖 Read the article in the Foundation's newsletter:https://fondation-diabete.ch/wp-content/uploads/2026/06/Newsletter_Diabete_2026.pdf

Hôpitaux Universitaires de Genève, Université de Genève

How can we better bridge the gap between   and   in global health?Join us for an insightful discussion on strengthening ...
03/06/2026

How can we better bridge the gap between and in global health?

Join us for an insightful discussion on strengthening health systems for Noncommunicable diseases ( ) and Neglected tropical diseases ( ), drawing on lessons from Southeast Asia, Mozambique, Nepal, and Peru.

Hosted by the NCD Policy Lab and the COHESION-I Project, in collaboration with global partners committed to advancing health systems and improving health outcomes in low- and middle-income countries ( ).

📅 11 June 2026 | 16:30
📍 Campus Biotech, Room H8-01-D - chemin des Mines 9, Geneva, Switzerland

Hear from researchers and experts from India, Mozambique, Nepal, and Peru as they share real-world experiences on translating evidence into policy and driving sustainable health system change.

Scan the QR code to register by 9 June 2026.
Registration link: https://docs.google.com/forms/d/e/1FAIpQLSfzMWOMtIJj7SHTuvsX_Px6zKskN6IhNwFH8v89KaxcekUdtQ/viewform

CRONICAS - Centro de Excelencia en Enfermedades Crónicas, Universidad Peruana Cayetano Heredia, University of Geneva, The George Institute for Global Health, NIHR (National Institute for Health and Care Research)

What a powerful day yesterday at  !From implementation gaps to sustainable financing, from policy alignment to digital i...
22/05/2026

What a powerful day yesterday at !

From implementation gaps to sustainable financing, from policy alignment to digital innovation grounded in real health system needs, yesterday’s discussions at the geneva digital health day made one thing clear: we need to move beyond pilots and toward real impact for people living with & conditions.

The NCD Policy Lab was proud to collaborate with Geneva Digital Health Hub (gdhub) as a partner of under the NCDs & Mental Health track, showcasing the aggregation system of the NCD Policy Lab platform developed by our partner HEPIA and highlighting inspiring country experiences from our partner CRONICAS - Centro de Excelencia en Enfermedades Crónicas, presented by Lourdes Cruzado Castro.
The track concluded with a rich and engaging panel discussion, moderated by the NCD Policy Lab, Marina Giachino bringing together key voices, Jackie Ogutu, Lourdes Cruzado Castro and Ken Carswell to reflect on how can truly strengthen health systems and advance the NCD agenda.

What stood out most? A shared recognition that stronger collaboration between researchers, policymakers, and implementers is essential to turn evidence into real-world impact for NCDs & mental health. This strongly resonate with our mission: bridging and , learning from country experiences, and co-creating context-adapted solutions to advance equitable access to care with digital health as a key enabler.

Congratulations to all participants, and especially to Geneva Digital Health Hub (gdhub), for bringing together such an inspiring community at such a timely moment during .

Access to   is not only an affordability issue.It is also a regulatory challenge.From WHO prequalification and quality a...
19/05/2026

Access to is not only an affordability issue.
It is also a regulatory challenge.

From WHO prequalification and quality assurance to regulatory harmonization and biosimilars, regulatory capacity plays a critical role in improving access to safe and effective insulin and associated medical devices, particularly in low- and middle-income countries.

🎥 Insulin and associated medical devices: what are the key regulatory challenges today?
Presented by Cécile Macé

▶ Watch the discussion: https://youtu.be/WIQIS2ux1RY?si=SWj7slUSR8-ye5ES

29/04/2026

A few months ago, the hackathon and brought together health professionals, students, innovators, experts, and changemakers to tackle one urgent challenge: improving equity in Noncommunicable disease care and access 🔵

What started as ideas quickly turned into concrete solutions.
But what happened next?

🎥 In this video, challenge owners look back on their experience and share how their solutions have evolved since the hackathon.

Curious to see where these ideas are now? Press play

👉 https://youtu.be/u2OLfBgrCgA?si=QpBPmKtxe3Ldmxv2



Université de Genève, Hôpitaux Universitaires de Genève, Geneva Digital Health Hub (gdhub), ONG Santé Diabète, NCD Alliance, International Committee of the Red Cross, Médecins Sans Frontières / MSF, Centre d'Expertise et de Recherche en Télémedecine et E_Santé Mali, DigiS@nté Mali, Faculté de Médecine et d'odonto-stomatologie FMOS Bamako-Mali

Turning ideas into impact starts with the right skills.Kudos to our partner HPACfor this hands-on training 👏Equipping re...
21/04/2026

Turning ideas into impact starts with the right skills.

Kudos to our partner HPACfor this hands-on training 👏
Equipping researchers with practical tools in project development and grant funding is key to strengthening health research and policy in .

Adresse

Geneva

Notifications

Soyez le premier à savoir et laissez-nous vous envoyer un courriel lorsque NCD Policy Lab publie des nouvelles et des promotions. Votre adresse e-mail ne sera pas utilisée à d'autres fins, et vous pouvez vous désabonner à tout moment.

Raccourcis

Partager